Companies

Estrella Immunopharma, Inc.

ESLA, ESLAW · CIK 0001844417 · operating

$0.09+0.00%Last updated Mar 2, 8:48 PM

Key Statistics

Valuation

Market Cap
P/E
Fwd P/E
PEG
P/S
P/B
EV/EBITDA
EV/Rev

Profitability

Gross Margin
Op. Margin
Net Margin
ROE-171.09%
ROA-164.15%
FCF Margin

Financial Health

Current Ratio24.65
Debt/Equity0.04
Free Cash Flow-$16.07M
Div. Yield

Growth & Other

Revenue Growth
EPS Growth
Beta-0.09
52W High$0.09
52W Low$0.09

About Estrella Immunopharma, Inc.

Estrella Immunopharma, Inc. (ESLAW) is a biological products, (no diagnostic substances) company, listed on the Nasdaq. The stock currently trades at $0.09, up 0.00% today, with a 52-week range of $0.09–$0.09.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-0.27$-0.27
2022
2021

Annual Reports (10-K) · 3 filings

Report DateFiledAccession Number
2024-06-302024-09-270001213900-24-082374SEC ↗
2022-12-312023-03-140001575872-23-000353SEC ↗
2021-12-312022-03-290001410578-22-000598SEC ↗